Ionis Pharmaceuticals IONS
NASDAQ IONS
$43.54 -0.46 (-1.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ionis Pharmaceuticals (IONS) Selling, General & Administrative (2009 - 2026)

Updated

Ionis Pharmaceuticals' Selling, General & Administrative was $150.4 million in Q2 2026, up 66.0% from $90.62 million a year earlier and unchanged from the prior quarter.

Analysis

Ionis Pharmaceuticals (IONS) Selling, General & Administrative (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ionis Pharmaceuticals' Selling, General & Administrative was $527.75 million through Jun 30, 2026, up 66.7% year-over-year; for FY2025, it was $393.87 million, up 47.3% from FY2024.

  • Selling, General & Administrative has now increased for three consecutive years, with a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $267.47 million in FY2024 (+15.0%), $232.62 million in FY2023 (+54.8%), $150.3 million in FY2022 (-19.3%) and $186.35 million in FY2021 (-47.4%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2009.
  • Compared with a year earlier, Selling, General & Administrative has increased for seven straight quarters, with growth averaging 45.5% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2023 (growth of 103.3%); the worst was Q4 2021 (a decline of 72.9%).
  • Per Business Quant data, IONS's Selling, General & Administrative in the three quarters before Q2 2026 was $150.36 million (Q1 2026), $130.19 million (Q4 2025) and $96.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Ionis Pharmaceuticals 7.21 Bn -1.68 Bn 265.21 Mn 150.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150.40 Mn
Mar 31, 2026 150.36 Mn
Dec 31, 2025 130.19 Mn
Sep 30, 2025 96.81 Mn
Jun 30, 2025 90.62 Mn
Mar 31, 2025 76.25 Mn
Dec 31, 2024 88.08 Mn
Sep 30, 2024 61.64 Mn
Jun 30, 2024 65.11 Mn
Mar 31, 2024 52.64 Mn
Dec 31, 2023 71.01 Mn
Sep 30, 2023 69.95 Mn
Jun 30, 2023 46.14 Mn
Mar 31, 2023 45.52 Mn
Dec 31, 2022 47.95 Mn
Sep 30, 2022 34.42 Mn
Jun 30, 2022 33.80 Mn
Mar 31, 2022 34.13 Mn
Dec 31, 2021 37.60 Mn
Sep 30, 2021 31.09 Mn
API Access

Ionis Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IONS&period=max&api_key=YOUR_API_KEY